phosphotyrosine has been researched along with Lymphoma, T-Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, C; Avery, KN; Chan, JK; Chan, WC; Cornish, A; d'Amore, F; de Leval, L; Fu, K; Gaulard, P; Gong, Q; Hu, X; Iqbal, J; Jiang, B; Kavak, P; Küçük, C; Lack, N; Leppä, S; Liu, W; McKeithan, T; Scuto, A; Sen, E; Staudt, L; Sun, H; Williams, JC; Xiao, W; Yang, Q; Zhang, W | 1 |
| Bi, C; Chng, WJ; Chung, TH; Lee, PT; Lee, XT; Li, B; Lin, B; Ng, SB; Selvarajan, V; Tan, J; Yan, J; Yang, H; Yu, Q | 1 |
| Arni, S; Hoessli, DC; Poincelet, M; Senaldi, G | 1 |
| Azuma, I; Matsuzawa, K; Saiki, I; Sato, K; Tono-Oka, S; Watanabe, R; Yoo, YC | 1 |
| Appella, E; Ashwell, JD; D'Oro, U; Sakaguchi, K | 1 |
| Coss, D; Ingleton, P; Kuo, CB; Luben, R; Walker, AM; Yang, L | 1 |
| Burakoff, SJ; Jin, YJ; Yu, CL | 1 |
| Aster, JC; Fletcher, JA; McCarthy, JG; Xiao, S | 1 |
| Carpentieri, DF; Majewski, M; Morris, S; Odum, N; Raghunath, PN; Skorski, T; Wasik, MA; Xue, L; Zhang, Q | 1 |
9 other study(ies) available for phosphotyrosine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
Topics: Binding Sites; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histidine; Humans; Interleukin-2; Janus Kinase 1; Killer Cells, Natural; Lymphoma, T-Cell; Mutation; Phosphotyrosine; Protein Structure, Tertiary; Receptors, Antigen, T-Cell, gamma-delta; STAT3 Transcription Factor; STAT5 Transcription Factor; T-Lymphocyte Subsets | 2015 |
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma.
Topics: Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Enzyme Activation; Gene Expression Regulation, Neoplastic; Histones; Humans; Janus Kinase 3; Lymphoma, T-Cell; Lysine; Methylation; Models, Biological; Natural Killer T-Cells; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Polycomb Repressive Complex 2; Protein Binding; Protein Kinase Inhibitors; Protein Subunits; RNA Polymerase II; Transcription Factors | 2016 |
Selective association of the p59fyn tyrosine kinase with murine T lymphoma membrane phosphoproteins.
Topics: Animals; Cell Cycle Proteins; Electrophoresis, Gel, Two-Dimensional; Lymphoma, T-Cell; Macromolecular Substances; Membrane Proteins; Mice; Oncogene Protein v-crk; Phosphoproteins; Phosphotyrosine; Precipitin Tests; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-vav; Retroviridae Proteins, Oncogenic; Tyrosine | 1993 |
Tolerance to the anti-metastatic effect of lipopolysaccharide against liver metastasis in mice.
Topics: Animals; Cytotoxicity, Immunologic; Drug Administration Schedule; Immunity, Cellular; Killer Cells, Natural; Lipopolysaccharides; Liver Neoplasms; Lymphoma, T-Cell; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Metastasis; Phosphotyrosine; Tumor Necrosis Factor-alpha | 1996 |
Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity.
Topics: Amino Acid Sequence; Base Sequence; DNA Mutational Analysis; Enzyme Activation; Humans; Leukocyte Common Antigens; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Lymphoma, T-Cell; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasm Proteins; Peptide Mapping; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Recombinant Fusion Proteins; src-Family Kinases; T-Lymphocyte Subsets; Transfection | 1996 |
Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Topics: Aspartic Acid; Cell Division; DNA-Binding Proteins; Enzyme Activation; Humans; Janus Kinase 2; Kinetics; Lymphoma, T-Cell; Milk Proteins; Molecular Mimicry; Mutagenesis; Phosphorylation; Phosphotyrosine; Prolactin; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Recombinant Proteins; Signal Transduction; STAT5 Transcription Factor; Structure-Activity Relationship; Trans-Activators; Tumor Cells, Cultured | 1999 |
Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.
Topics: Biological Transport; Cell Line; Cell Nucleus; Cytosol; DNA-Binding Proteins; Down-Regulation; Interleukin-2; Intracellular Signaling Peptides and Proteins; Lymphoma, T-Cell; Milk Proteins; Mutation; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Biosynthesis; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; STAT5 Transcription Factor; Trans-Activators; Tumor Cells, Cultured | 2000 |
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
Topics: Animals; Binding Sites; Carrier Proteins; Cell Transformation, Neoplastic; DNA-Binding Proteins; Enzyme Activation; Hematopoietic Stem Cells; Lymphoma, T-Cell; Macromolecular Substances; Mice; Phosphorylation; Phosphotyrosine; Proline; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Recombinant Fusion Proteins; Structure-Activity Relationship; Transcription Factors; Tumor Cells, Cultured | 2000 |
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.
Topics: Anaplastic Lymphoma Kinase; Carrier Proteins; Cell Line; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lymphoma, T-Cell; Models, Biological; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Phosphatase 2; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; RNA, Neoplasm; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Up-Regulation | 2002 |